Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuroNet-PHL-LP1
NCT01088750Phase 4Completed
- Start
- Nov 2009
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide, vinblastine, prednisolone in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). Started Nov 2009; status: completed.
02
Drugs
cyclophosphamidevinblastineprednisolone
03
Conditions
nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)
Beyond the preview
Go deeper on NCT01088750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088750.